Comorbidity of mental and musculoskeletal disorders in ageing women: A data linkage study using national registries

Abstract

BackgroundMental disorders (MDs) and musculoskeletal disorders (MSDs) are the main causes of disability. Yet, their comorbidity has not received the deserved attention. ObjectiveTo investigate the extent of the comorbidity between MDs and MSDs in ageing women using national registries on prescription medications and work disability pensions (DPs). MethodsThe study included 7,809 Finnish women, born during 1932–41, from the population-based Kuopio Osteoporosis Risk Factor and Prevention Study (OSTPRE) cohort, established in 1989. Lifetime permanent DPs due to: 1) ‘MDs only’ (n = 359), 2) ‘MSDs only’ (n = 954), 3) ‘MDs + MSDs’ (n = 227), were recorded till 2003. The reference group was ‘no DP’ (n = 6,269). Data from the OSTPRE questionnaires was obtained in 1994. Use of medications was recorded in 1995 and 2003. The use of musculoskeletal or psychotropic medications by women having a DP or medication due to MD, or MSD diagnoses, respectively, was considered as an indicator of comorbidity. ResultsIn 1995, all DP groups had used psychotropic and musculoskeletal medications more often than the referents. Use of musculoskeletal medications was associated with a higher use of psychotropic medications, and vice versa (OR=2.45; 95% CI 2.17–2.77), compared with non-use. The ‘MSDs only’ group was more likely to use psychotropic (OR=1.79; 95% CI 1.50–2.12), and the ‘MDs only’ group musculoskeletal medications (OR=1.38; 95% CI 1.09–1.74), compared with those without DPs. The proportions of medication users were similar in 1995 and 2003; however, the amounts used increased. ConclusionsThere was strong evidence for comorbidity between MDs and MSDs in ageing women. Further research concerning their longitudinal relationships is warranted.